Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
University Library
Adelaide Festival of Ideas
Barr Smith Press
Friends of the University of Adelaide Library
Library Publications
Internal documents (Library staff only)
Library images
Library reports and papers
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-7 of 7 (Search time: 0.002 seconds).
previous
1
next
Item hits:
Preview
Issue Date
Title
Author(s)
2012
Drug-interaction studies evaluating T-cell proliferation reveal distinct activity of dasatinib and imatinib in combination with cyclosporine A
Blake, S.
;
Hughes, T.
;
Lyons, A.
2012
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Nieborowska-Skorska, M.
;
Kopinski, P.
;
Ray, R.
;
Hoser, G.
;
Ngaba, D.
;
Flis, S.
;
Cramer, K.
;
Reddy, M.
;
Koptyra, M.
;
Penserga, T.
;
Glodkowska-Mrowka, E.
;
Bolton, E.
;
Holyoake, T.
;
Eaves, C.
;
Cerny-Reiterer, S.
;
Valent, P.
;
Hochhaus, A.
;
Hughes, T.
;
Van der Kuip, H.
;
Sattler, M.
;
et al.
2012
BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management
Branford, S.
;
Yeung, D.
;
Prime, J.
;
Choi, S.
;
Bang, J.
;
Park, J.
;
Kim, D.
;
Ross, D.
;
Hughes, T.
2012
Classification of patients with chronic myeloid leukemia on basis of BCR-ABL transcript level at 3 months fails to identify patients with low organic cation transporter-1 activity destined to have poor imatinib response
White, D.
;
Hughes, T.
2012
Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profile
Parker, W.
;
Ho, M.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
2012
Initial molecular response at 3 months may predict both response and event-free survival at 24 months in Imatinib-resistant or -intolerant patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with Nilotinib
Branford, S.
;
Kim, D.
;
Soverini, S.
;
Haque, A.
;
Shou, Y.
;
Woodman, R.
;
Kantarjian, H.
;
Martinelli, G.
;
Radich, J.
;
Saglio, G.
;
Hochhaus, A.
;
Hughes, T.
;
Muller, M.
2012
Therapeutic targeting of BCR-ABL: prognostic markers of response and resistance mechanism in chronic myeloid leukaemia
Yeung, D.
;
Hughes, T.
Discover
Author
3
Branford, S.
2
Hochhaus, A.
2
Kim, D.
2
Yeung, D.
1
Bang, J.
1
Blake, S.
1
Bolton, E.
1
Cerny-Reiterer, S.
1
Choi, S.
1
Cramer, K.
.
next >
Subject
6
Fusion Proteins, bcr-abl
5
Piperazines
5
Pyrimidines
4
Benzamides
4
Drug Resistance, Neoplasm
4
Imatinib Mesylate
4
Leukemia, Myelogenous, Chronic, B...
4
Protein Kinase Inhibitors
3
Antineoplastic Agents
3
Leukemia, Myeloid, Chronic-Phase
.
next >